| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/11/2003 | US20030171430 Dissolving in iodinated poppyseed oil fatty ester |
| 09/11/2003 | US20030171429 Anti-inflammatory and psoriasis treatment and protein kinase inhibition by hydroxyltilbenes and novel stilbene derivatives and analogues |
| 09/11/2003 | US20030171426 Antilipemic agents; atherosclerosis; anticholesterol agents; cardiovascular disorders |
| 09/11/2003 | US20030171423 Enzyme inhibitor for treating HIV infections in mammals; viricides; patient is suffering from a multi-drug resistant HIV infection; AIDS therapy |
| 09/11/2003 | US20030171422 Aldose reductase inhibitors; antidiabetic agents |
| 09/11/2003 | US20030171420 Using a thiolactomycin compound as parasiticide |
| 09/11/2003 | US20030171419 Pharmaceutical compositions comprising fluvastatin |
| 09/11/2003 | US20030171418 Pyranoindazoles and their use for the treatment of glaucoma |
| 09/11/2003 | US20030171417 Double salts of fumaric acid with a carnitine and an amino acid and food supplements, dietary supplements and drugs containing same |
| 09/11/2003 | US20030171416 Nordihydroguaiaretic acid; anticancer agents, viricides |
| 09/11/2003 | US20030171415 Strokes; cardiovascular disorders; mixture of melmisartan and ramipril |
| 09/11/2003 | US20030171414 Valsartan; hypotensive agents, cardiovascular disorders, anticholesterol agents, antilipemic agents |
| 09/11/2003 | US20030171413 Rheumatic diseases; antiarthritic agents; asthma |
| 09/11/2003 | US20030171411 Amide derivatives as therapeutic agents |
| 09/11/2003 | US20030171407 Synergistic mixture of insulin secretory stimulant and enzyme inhibitor; hypoglycemic agents, antidiabetic agents |
| 09/11/2003 | US20030171406 Medicinal compositions containing propenone derivatives |
| 09/11/2003 | US20030171405 Reducing concentration of glucose, triglycerides; antidiabtic agents |
| 09/11/2003 | US20030171404 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors |
| 09/11/2003 | US20030171403 Blockade of voltage dependent sodium channels |
| 09/11/2003 | US20030171402 Method of treating neutrophil-related diseases with topical anesthetics |
| 09/11/2003 | US20030171401 Insertion drug delivery device containing fentanyl |
| 09/11/2003 | US20030171400 Rheumatic diseases; osteoporosis; multiple sclerosis; autoimmune disease; joint replacements |
| 09/11/2003 | US20030171398 Plant extract; antidiabetic agents |
| 09/11/2003 | US20030171395 Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands |
| 09/11/2003 | US20030171393 Drugs for sex dysfunctions |
| 09/11/2003 | US20030171392 Substituted indeno[1,2-c]isoquinoline derivatives and methods of use thereof |
| 09/11/2003 | US20030171391 Headaches; muscular disorders; antiinflammatory agents |
| 09/11/2003 | US20030171389 Anticancer agents; bone disorders; antiarthritic agents |
| 09/11/2003 | US20030171388 Vitamins injected into gel spheres of various colors; mixture of orotic acid and carnitine |
| 09/11/2003 | US20030171386 Small molecules for the treatment of abnormal cell growth |
| 09/11/2003 | US20030171385 Synergistic enhancement of cognitive ability |
| 09/11/2003 | US20030171384 8-Quinolinxanthine and 8-isoquinolinxanthine derivatives as pde 5 inhibitors |
| 09/11/2003 | US20030171383 Administering adenosine A2 receptor antagonist |
| 09/11/2003 | US20030171382 Pharmaceutical composition for regeneration of cirrhotic liver |
| 09/11/2003 | US20030171381 Therapy for Parkinson's disease; antidepressants; antiepileptic agents |
| 09/11/2003 | US20030171380 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands |
| 09/11/2003 | US20030171379 Skin disorders; antiarthritic agents; Crohn's disease |
| 09/11/2003 | US20030171378 Indolinone derivatives |
| 09/11/2003 | US20030171375 Method for treating ocular neovascular diseases |
| 09/11/2003 | US20030171374 Viricides; prevent reproduction of human T-Cell lymphocyte virus |
| 09/11/2003 | US20030171373 Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation |
| 09/11/2003 | US20030171370 Phenoxyalkylamine derivatives useful as opioid receptor agonists |
| 09/11/2003 | US20030171366 Having antibacterial activity against Gram-positive and Gram-negative bacteria |
| 09/11/2003 | US20030171365 Inhibitors of the interleukin-1beta conversion enzyme; useful in treatment of inflammatory, auto-immune and neurodegenerative diseases |
| 09/11/2003 | US20030171364 Phosphodiesterase inhibitor compounds; therapeutic activity as anti-inflammatory and anti-allergic medicinal products, and in the treatment of various respiratory diseases such as asthma |
| 09/11/2003 | US20030171363 Non-nucleoside reverse transcriptase inhibitors |
| 09/11/2003 | US20030171362 Amino-tetralin derivatives as muscarinic receptor antagonists |
| 09/11/2003 | US20030171361 Treatment of impotence, sexual dysfunction in female, stable, unstable and variant angina, hypertension, pulmonary hypertension, congestive heart failure, atherosclerosis |
| 09/11/2003 | US20030171360 Piperidines |
| 09/11/2003 | US20030171359 Suitable for treatment of illnesses characterised by excessive or abnormal cell proliferation; viral, bacterial, fungal and/or parasitic infections, skin diseases, bone diseases, cardiovascular diseases |
| 09/11/2003 | US20030171358 New compounds, their preparation and use |
| 09/11/2003 | US20030171357 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 09/11/2003 | US20030171356 Methods for alzheimer's disease treatment and cognitive enhancement |
| 09/11/2003 | US20030171354 Indole derivatives |
| 09/11/2003 | US20030171353 Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands |
| 09/11/2003 | US20030171352 Sulfonylaminocarboxylic acid N-arylamides as guanylate cyclase activators |
| 09/11/2003 | US20030171348 Diagnosis and management of infection caused by Chlamydia |
| 09/11/2003 | US20030171345 8Beta-substituted 11beta-aryl-estra-1,3,5,(10)-triene derivatives |
| 09/11/2003 | US20030171343 Preparation for external use is a patch that a pressure-sensitive adhesive layer containing a steroidal antiphlogistic is provided on a support, and the pressure-sensitive adhesive layer further contains a |
| 09/11/2003 | US20030171342 Novel 16-ene-C25-oxime and 16-ene- C-25-oxime ether analogs of 1 alpha ,25-dihydroxy vitamin D3, compositions comprising these compounds and methods of using these compounds as inhibitors of CYP24. |
| 09/11/2003 | US20030171340 Treating antibiotic-resistant infections with a metal complex of tetracycline, glycylcycline, or quinolone antibiotics, or administering a metal compound and the antibiotic together for in situ formation of the complex |
| 09/11/2003 | US20030171339 Novel retinoid derivatives and methods for producing said compounds and anti-cancer pharmaceutical composition comprising said compounds |
| 09/11/2003 | US20030171338 Novel cytotoxic compounds and their Use |
| 09/11/2003 | US20030171337 Useful in the treatment and prophylaxis of inflammatory conditions or in the amelioration of symptoms resulting from or facilitated by an inflammatory condition in a mammalian animal including human and primate, non-mammalian animal and |
| 09/11/2003 | US20030171335 Antisense antiviral agent and method for treating ssRNA viral infection |
| 09/11/2003 | US20030171334 Treatment of prostate cancer |
| 09/11/2003 | US20030171333 Pharmaceutical composition containing at least a polymer combined with or conjugated to at least a phenylalkylcarboxylic acid salt, conjugate polymers and uses thereof |
| 09/11/2003 | US20030171332 Preventing bronchoconstriction induced by neutrophil elastase and tissue kallikrein activity. The method includes administration of aerosolized hyaluronic acid in an amount sufficient to bind to RHAMM (CD168) receptors along the |
| 09/11/2003 | US20030171331 Oxazolidinone cotherapy |
| 09/11/2003 | US20030171330 Antibacterial compound |
| 09/11/2003 | US20030171329 Stable compositions comprising tezacitabine |
| 09/11/2003 | US20030171323 Specifically for granuloma occurring after ligation of a deferent duct, comprising an antagonist against the scavenger receptor of macrophage, such as antibody, as an active ingredient. |
| 09/11/2003 | US20030171321 Immunostimulatory oligodeoxynucleotides |
| 09/11/2003 | US20030171320 Methods for treating ocular neovascular diseases |
| 09/11/2003 | US20030171317 Methods and compositions for reducing bacterial tolerance to antibacterials, disinfectants and organic solvents |
| 09/11/2003 | US20030171309 Pharmaceutically active pyrrolidine derivatives as bax inhibitors |
| 09/11/2003 | US20030171307 Equilibrium mixture of azalide isomers, water, and one or more acids, and methods for preparing such compositions, are disclosed. The antibiotic compositions can be advantageously stabilized by adding one or more water-miscible co-solvents |
| 09/11/2003 | US20030171306 Cancer treatment method |
| 09/11/2003 | US20030171302 Opioid derivative |
| 09/11/2003 | US20030171300 Treating different types and symptoms of acute and chronic pain, especially non neuropathic inflammatory pain in mammals. The pain to be treated may be e.g. chronic inflammatory pain, rheumatoid arthritis pain and/or secondary |
| 09/11/2003 | US20030171299 Stable, biologically compatible pharmaceutical compositions in the form of water-in-oil microemulsions (w/o), for the sustained release by parenteral administration of active ingredients which are hydrophilic or are made hydrophilic by |
| 09/11/2003 | US20030171287 Medicinal compositions for angiogenic therapy |
| 09/11/2003 | US20030171281 Therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, in the treatment of microorganism-caused infections, which infections may be systemic, such as a |
| 09/11/2003 | US20030171270 Therapeutic compositions and methods relating to prolactin releasing peptide (PrRP) |
| 09/11/2003 | US20030171263 Methods for treating transplant rejection |
| 09/11/2003 | US20030171252 Nucleic acid molecules are provided encoding novel polypeptides. Novel polypeptides and antibodies that bind to these polypeptides are provided. Also provided are vectors, host cells, and recombinant and synthetic methods for human |
| 09/11/2003 | US20030171251 Treatment and prevention of tissue damage |
| 09/11/2003 | US20030170895 Methods of making hypermutable cells using PMSR homologs |
| 09/11/2003 | US20030170893 Nanocapsule encapsulation system and method |
| 09/11/2003 | US20030170872 Mutagenic nucleoside analogs for the treatment of viral disease |
| 09/11/2003 | US20030170858 Gyrase inhibitors and uses thereof |
| 09/11/2003 | US20030170839 Type 2 cytokine receptor and nucleic acids encoding same |
| 09/11/2003 | US20030170831 Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same |
| 09/11/2003 | US20030170785 CDNA encoding the human alpha2 delta4 calcium channel subunit |
| 09/11/2003 | US20030170782 Proteins |
| 09/11/2003 | US20030170754 Anticancer agents; diagnosis of prostate cancer |
| 09/11/2003 | US20030170741 Methods for identifying compounds for regulating muscle mass or function using dopamine receptors |
| 09/11/2003 | US20030170643 Regulation of apoB treatment and drug screening for cardiovascular and metabolic disorders or syndromes |
| 09/11/2003 | US20030170381 Piezoelectric element and process for production thereof |
| 09/11/2003 | US20030170329 Cytokine production inhibitors, agents for protecting and promoting liver funtion, anti-inflammatory agents, immunosuppressants, drugs, cosmetics, foods and food materials |